326 related articles for article (PubMed ID: 9933097)
1. CD4 T cells can reject major histocompatibility complex class I-incompatible skin grafts.
Wise M; Zelenika D; Bemelman F; Latinne D; Bazin H; Cobbold S; Waldmann H
Eur J Immunol; 1999 Jan; 29(1):156-67. PubMed ID: 9933097
[TBL] [Abstract][Full Text] [Related]
2. Rejection of grafts with no H-2 disparity in TAP1 mutant mice: CD4 T cells are important effector cells and self H-2b class I molecules are target.
Suárez IM; Benvenutti LA; Noronh I; Van Kaer L; Kalil J; Coelho V
Transpl Immunol; 2002 May; 9(2-4):101-10. PubMed ID: 12180815
[TBL] [Abstract][Full Text] [Related]
3. Specific tolerance induction of allo-K(b)-skin grafts by FK506 in the CD8-depleted H-2(k) recipients required low amounts of K(b)-antigen.
Chen BG; Liu Z; Wu Y
Transpl Immunol; 2005 Oct; 15(1):9-16. PubMed ID: 16223668
[TBL] [Abstract][Full Text] [Related]
4. Adoptively transferred CD4+ lymphocytes from CD8 -/- mice are sufficient to mediate the rejection of MHC class II or class I disparate skin grafts.
Dalloul AH; Chmouzis E; Ngo K; Fung-Leung WP
J Immunol; 1996 Jun; 156(11):4114-9. PubMed ID: 8666777
[TBL] [Abstract][Full Text] [Related]
5. CD8+ effector cells responding to residual class I antigens, with help from CD4+ cells stimulated indirectly, cause rejection of "major histocompatibility complex-deficient" skin grafts.
Lee RS; Grusby MJ; Laufer TM; Colvin R; Glimcher LH; Auchincloss H
Transplantation; 1997 Apr; 63(8):1123-33. PubMed ID: 9133474
[TBL] [Abstract][Full Text] [Related]
6. Cellular basis of skin allograft rejection across a class I major histocompatibility barrier in mice depleted of CD8+ T cells in vivo.
Rosenberg AS; Munitz TI; Maniero TG; Singer A
J Exp Med; 1991 Jun; 173(6):1463-71. PubMed ID: 1674524
[TBL] [Abstract][Full Text] [Related]
7. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.
Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV
Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571
[TBL] [Abstract][Full Text] [Related]
8. CD4-negative cytotoxic T cells with a T cell receptor alpha/beta intermediate expression in CD8-deficient mice.
Dalloul AH; Ngo K; Fung-Leung WP
Eur J Immunol; 1996 Jan; 26(1):213-8. PubMed ID: 8566069
[TBL] [Abstract][Full Text] [Related]
9. Skin graft rejection elicited by beta 2-microglobulin as a minor transplantation antigen involves multiple effector pathways: role of Fas-Fas ligand interactions and Th2-dependent graft eosinophil infiltrates.
Surquin M; Le Moine A; Flamand V; Nagy N; Rombaut K; Demoor FX; Stordeur P; Salmon I; Guéry JC; Goldman M; Abramowicz D
J Immunol; 2002 Jul; 169(1):500-6. PubMed ID: 12077281
[TBL] [Abstract][Full Text] [Related]
10. CD4+ T cell-mediated rejection of major histocompatibility complex class I-disparate grafts: a role for alloantibody.
Morton AL; Bell EB; Bolton EM; Marshall HE; Roadknight C; McDonagh M; Bradley JA
Eur J Immunol; 1993 Sep; 23(9):2078-84. PubMed ID: 8103742
[TBL] [Abstract][Full Text] [Related]
11. Two levels of help for B cell alloantibody production.
Steele DJ; Laufer TM; Smiley ST; Ando Y; Grusby MJ; Glimcher LH; Auchincloss H
J Exp Med; 1996 Feb; 183(2):699-703. PubMed ID: 8627185
[TBL] [Abstract][Full Text] [Related]
12. Rejection of H-Y disparate skin grafts by monospecific CD4+ Th1 and Th2 cells: no requirement for CD8+ T cells or B cells.
Zelenika D; Adams E; Mellor A; Simpson E; Chandler P; Stockinger B; Waldmann H; Cobbold SP
J Immunol; 1998 Aug; 161(4):1868-74. PubMed ID: 9712055
[TBL] [Abstract][Full Text] [Related]
13. CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II.
Pietra BA; Wiseman A; Bolwerk A; Rizeq M; Gill RG
J Clin Invest; 2000 Oct; 106(8):1003-10. PubMed ID: 11032860
[TBL] [Abstract][Full Text] [Related]
14. Allograft rejection in athymic nude rats by transferred T cell subsets. II. The response of naive CD4+ and CD8+ thoracic duct lymphocytes to an isolated MHC class I disparity.
Bell EB; Rejali D; Whitby EH; Sparshott SM; Yang CP
Transplantation; 1990 Oct; 50(4):690-6. PubMed ID: 1977220
[TBL] [Abstract][Full Text] [Related]
15. Rejection of grafts without histocompatibility antigen disparity by TAP1-/- mice: a role for CD4+ T cells.
Marrero I; Benvenutti LA; Noronha I; Kalil J; Coelho V
Transplant Proc; 2004 May; 36(4):999-1000. PubMed ID: 15194347
[TBL] [Abstract][Full Text] [Related]
16. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway.
Ito A; Shimura H; Nitahara A; Tomiyama K; Ito M; Kanekura T; Okumura K; Yagita H; Kawai K
Int Immunol; 2008 Oct; 20(10):1343-9. PubMed ID: 18697765
[TBL] [Abstract][Full Text] [Related]
17. Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans.
Martin PJ
J Exp Med; 1993 Aug; 178(2):703-12. PubMed ID: 8101864
[TBL] [Abstract][Full Text] [Related]
18. A role for Th2 cytokines in the suppression of CD8+ T cell-mediated graft rejection.
Scully R; Cobbold SP; Mellor AL; Wissing M; Arnold B; Waldmann H
Eur J Immunol; 1997 Jul; 27(7):1663-70. PubMed ID: 9247575
[TBL] [Abstract][Full Text] [Related]
19. CD4+ T cells are able to reject class I disparate allografts.
Sawada T; Wu Y; Sachs DH; Iacomini J
Transplantation; 1997 Jul; 64(2):335-40. PubMed ID: 9256197
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules.
Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K
Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
